BWXT

Over the past six months, BWXT's stock price decreased by approximately 26%, reaching a 52-week low of $144.06, despite a robust contract backlog and positive fundamental catalysts. Key events included strong Q1 2026 earnings with revenue up 26% and adjusted EBITDA up 14%, and the acquisition of Precision Components Group in April 2026 to boost commercial nuclear manufacturing capacity. Q2 2026 saw revenue increase by 18% and adjusted earnings per share of US$1.07, with the backlog jumping 40% to US$8.4 billion. BWXT was selected for the U.S. Army's Janus Program in August 2026, leading to a surge in shares, and secured a US$4 million design contract from the DOE/NNSA in September 2026 for a Lithium Processing Facility. Analyst ratings during July-September 2026 included 'Buy' from Jefferies ($181 target), 'Strong-Buy' from Guggenheim ($192 target), an upgrade to 'equal weight' from Wells Fargo (target lowered to $170), and an 'overweight' rating from JPMorgan Chase & Co. ($230 target).